Sonal Adhesives Ltd Upgraded from Strong Sell to Sell on Technical and Valuation Improvements

Technical Trend Shift Spurs Upgrade

The primary catalyst for the rating upgrade lies in the company’s technical trend, which has transitioned from mildly bearish to mildly bullish. Key technical indicators underpinning this shift include a bullish Moving Average Convergence Divergence (MACD) on the weekly chart and a mildly bullish MACD on the monthly chart. Additionally, Bollinger Bands readings are bullish on both weekly and monthly timeframes, suggesting increased price momentum and reduced volatility risk.

Other technical signals such as the Know Sure Thing (KST) indicator and Dow Theory assessments have also turned mildly bullish on weekly and monthly scales. However, the daily moving averages remain mildly bearish, indicating some short-term caution. The Relative Strength Index (RSI) on weekly and monthly charts currently shows no clear signal, reflecting a neutral momentum stance.

These technical improvements have contributed significantly to the upgrade, as the stock price has responded positively, rising 2.69% on the day to ₹48.92, with intraday highs touching ₹48.95. The 52-week price range remains broad, from a low of ₹30.40 to a high of ₹57.69, indicating potential for further upside if bullish momentum sustains.

Valuation Moves from Attractive to Fair

Alongside technical improvements, Sonal Adhesives’ valuation grade has been revised from attractive to fair. The company currently trades at a price-to-earnings (PE) ratio of 19.13, which is moderate relative to its peers in the plastic products and commodity chemicals sectors. Its price-to-book value stands at 2.87, while enterprise value to EBITDA is 17.17, reflecting a balanced valuation stance.

Return on capital employed (ROCE) is modest at 5.29%, and return on equity (ROE) is 14.98%, indicating reasonable profitability but room for improvement. The enterprise value to capital employed ratio is 1.63, suggesting efficient use of capital relative to market valuation. Compared to peers such as Apollo Pipes, which is rated very expensive with a PE of 286.75, Sonal Adhesives appears fairly valued, justifying the upgrade in valuation grade.

Despite the fair valuation, the absence of dividend yield and a PEG ratio of zero highlight limited growth expectations priced in by the market. Investors should note that while valuation has improved, it remains cautious given the company’s financial trends.

Financial Trend Remains Flat with Mixed Signals

Financially, Sonal Adhesives has delivered flat performance in the fourth quarter of FY25-26, with return on capital employed at a low 10.77% for the half year. The company’s net sales have grown at an impressive annual rate of 49.43% over the long term, signalling healthy top-line expansion. However, profits have declined by 12.4% over the past year, reflecting margin pressures or cost challenges.

Over the last year, the stock has generated a negative return of 9.74%, underperforming the BSE500 benchmark consistently for three consecutive years. This underperformance is a concern for investors seeking stable returns. The company’s promoter group remains the majority shareholder, providing some stability in ownership.

Overall, the financial trend remains flat to mildly negative, which tempers enthusiasm despite technical and valuation improvements.

Quality Assessment and Market Returns

Sonal Adhesives holds a Mojo Score of 41.0 with a Mojo Grade of Sell, upgraded from Strong Sell on 30 June 2026. The micro-cap company’s quality metrics reflect challenges, with a relatively low ROCE and flat quarterly results. However, the stock’s long-term returns have been impressive, with a five-year return of 608.99% and a ten-year return of 314.23%, significantly outperforming the Sensex’s 45.72% and 183.26% respectively over the same periods.

Shorter-term returns have been more volatile, with a one-week gain of 26.25% and one-month gain of 15.11%, both substantially outperforming the Sensex. Year-to-date returns are positive at 8.66%, while the one-year and three-year returns remain negative, underscoring the stock’s cyclical nature and sensitivity to market conditions.

Technical and Valuation Improvements Temper Financial Concerns

The upgrade to Sell from Strong Sell reflects a nuanced view of Sonal Adhesives’ prospects. While financial performance remains flat and profitability metrics are subdued, the improved technical indicators suggest a potential turnaround in market sentiment. The fair valuation relative to peers also supports a more constructive stance compared to the previous rating.

Investors should weigh the company’s strong long-term sales growth against recent profit declines and underperformance relative to benchmarks. The stock’s recent price action, supported by bullish weekly and monthly technical signals, may offer short- to medium-term trading opportunities, but fundamental challenges warrant caution.

Given the micro-cap status and sector volatility, Sonal Adhesives remains a speculative investment. The upgrade signals a reduction in downside risk but does not yet indicate a full recovery or strong buy recommendation.

Outlook and Investor Considerations

Looking ahead, Sonal Adhesives’ ability to convert sales growth into sustainable profit gains will be critical. Improvements in operational efficiency, margin expansion, and capital utilisation could drive further upgrades in quality and financial trend ratings. Meanwhile, monitoring technical indicators will remain important for timing entry and exit points.

Investors should also consider the broader commodity chemicals sector dynamics and peer valuations when assessing Sonal Adhesives. The company’s current fair valuation and technical momentum provide a foundation for cautious optimism, but the flat financial trend and recent profit declines suggest a watchful approach is prudent.

In summary, the upgrade to Sell from Strong Sell reflects a balanced reassessment of Sonal Adhesives Ltd, driven primarily by improved technical trends and a more reasonable valuation, offset by ongoing financial challenges and underperformance against benchmarks.

Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today